Citations (147)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Zhi-Xu He, Xiao-Wu Chen, Zhi-Wei Zhou & Shu-Feng Zhou. (2015) Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine. Drug Metabolism Reviews 47:4, pages 470-519.
Read now
Read now
Robert J Riley & Claire E Wilson. (2015) Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modelling. Expert Opinion on Drug Metabolism & Toxicology 11:4, pages 557-572.
Read now
Read now
Dong Gui Hu, Robyn Meech, Ross A. McKinnon & Peter I. Mackenzie. (2014) Transcriptional regulation of human UDP-glucuronosyltransferase genes. Drug Metabolism Reviews 46:4, pages 421-458.
Read now
Read now
Vicki M. Richardson, Stephen S. Ferguson, Yusupha M. Sey & Michael J. DeVito. (2014) In vitro metabolism of thyroxine by rat and human hepatocytes. Xenobiotica 44:5, pages 391-403.
Read now
Read now
Brigitte Gerin, Sylvie Dell’Aiera, Lysiane Richert, Steven Smith & Hugues Chanteux. (2013) Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy. Xenobiotica 43:4, pages 320-335.
Read now
Read now
Edward L. LeCluyse, Rafal P. Witek, Melvin E. Andersen & Mark J. Powers. (2012) Organotypic liver culture models: Meeting current challenges in toxicity testing. Critical Reviews in Toxicology 42:6, pages 501-548.
Read now
Read now
Imen Ayed-Boussema, Jean Marc Pascussi, Chiraz Zaied, Patrick Maurel, Hassen Bacha & Wafa Hassen. (2012) Ochratoxin A induces CYP3A4, 2B6, 3A5, 2C9, 1A1, and CYP1A2 gene expression in primary cultured human hepatocytes: a possible activation of nuclear receptors. Drug and Chemical Toxicology 35:1, pages 71-80.
Read now
Read now
Irene Antolino-Lobo, Jan Meulenbelt, Martin van den Berg & Majorie
B.M. van Duursen. (2011) A mechanistic insight into 3,4-methylenedioxymethamphetamine (“ecstasy”)-mediated hepatotoxicity. Veterinary Quarterly 31:4, pages 193-205.
Read now
Read now
A. Kaneko, M. Kato, C. Endo, K. Nakano, M. Ishigai & K. Takeda. (2010) Prediction of clinical CYP3A4 induction using cryopreserved human hepatocytes. Xenobiotica 40:12, pages 791-799.
Read now
Read now
Yan Li, Diansong Zhou, Stephen S. Ferguson, Peter Dorff, Thomas R. Simpson & Scott W. Grimm. (2010) In vitro assessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P450 enzyme identification, inhibition, and induction studies. Xenobiotica 40:11, pages 721-729.
Read now
Read now
Brandon Swift*Nathan D. Pfeifer*Kim L.R. Brouwer. (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metabolism Reviews 42:3, pages 446-471.
Read now
Read now
David E. Amacher. (2010) The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies. Toxicology Mechanisms and Methods 20:4, pages 159-166.
Read now
Read now
Masashi Honma, Masanari Kozawa & Hiroshi Suzuki. (2010) Methods for the quantitative evaluation and prediction of CYP enzyme induction using human in vitro systems. Expert Opinion on Drug Discovery 5:5, pages 491-511.
Read now
Read now
A. Kaneko, M. Kato, N. Sekiguchi, T. Mitsui, K. Takeda & Y. Aso. (2009) In vitro model for the prediction of clinical CYP3A4 induction using HepaRG cells. Xenobiotica 39:11, pages 803-810.
Read now
Read now
Katsutoshi Yoshizato & Chise Tateno. (2009) In vivo modeling of human liver for pharmacological study using humanized mouse. Expert Opinion on Drug Metabolism & Toxicology 5:11, pages 1435-1446.
Read now
Read now
Maria A Croyle. (2009) Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem. Expert Opinion on Drug Metabolism & Toxicology 5:10, pages 1189-1211.
Read now
Read now
Franz Oesch. (2009) Importance of knowledge on drug metabolism for the safe use of drugs in humans. Drug Metabolism Reviews 41:3, pages 298-300.
Read now
Read now
B. G. Lake. (2009) Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica 39:8, pages 582-596.
Read now
Read now
D. K. Walker, J. Davis, C. Houle, I. B. Gardner & R. Webster. (2009) Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerations. Xenobiotica 39:7, pages 534-543.
Read now
Read now
J. R. Kenny, L. Chen, D. F. McGinnity, K. Grime, K. M. Shakesheff, B. Thomson & R. Riley. (2008) Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies. Xenobiotica 38:12, pages 1500-1517.
Read now
Read now
Gregor Tuschl, Birthe Lauer & Stefan O Mueller. (2008) Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 855-870.
Read now
Read now
Articles from other publishers (126)
Yoshiyuki Ohno, Toyohito Oriyama, Akira Honda, Mineo Kurokawa & Tappei Takada. (2023) Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration. Journal of Pharmaceutical Health Care and Sciences 9:1.
Crossref
Crossref
Nuria Oliva-Vilarnau, Sabine U. Vorrink, Florian A. Büttner, Timo Heinrich, Janike Sensbach, Isabel Koscielski, Dirk Wienke, Carl Petersson, Dominique Perrin & Volker M. Lauschke. (2023) Comparative analysis of YAP/TEAD inhibitors in 2D and 3D cultures of primary human hepatocytes reveals a novel non-canonical mechanism of CYP induction. Biochemical Pharmacology 215, pages 115755.
Crossref
Crossref
Andleeb Shahzadi, Ceren Eyileten, Marek Postula, Esra Guzel Tanoglu, Omer Faruk Karatas, Ali Boray Basci, Oner Suzer & Zeliha Yazici. (2022) Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function. Naunyn-Schmiedeberg's Archives of Pharmacology 396:7, pages 1547-1561.
Crossref
Crossref
Madhuri BasakKiran DasTarun MahataAbhishek Singh SengarSumit Kumar VermaSayan BiswasKakali BhadraAdele StewartBiswanath Maity. (2023) RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα. Antioxidants & Redox Signaling 38:1-3, pages 137-159.
Crossref
Crossref
Kevin J. Coe, Mark Feinstein, J. William Higgins, Perry Leung, Brian P. Scott, Judy Skaptason, Yuen Tam, Laurie P. Volak, Jennifer Kinong, Anton Bittner, Heather McAllister, Nathan M. Lim, Michael Hack & Tatiana Koudriakova. (2022) Characterization of JNJ-2482272 [4-(4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazole-5-yl) Pyrimidine-2-Amine] As a Strong Aryl Hydrocarbon Receptor Activator in Rat and Human. Drug Metabolism and Disposition 50:8, pages 1064-1076.
Crossref
Crossref
Shujun Fu, Feifei Yu, Zhuohan Hu & Tao Sun. (2022) Metabolism-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations. Medicine in Drug Discovery 14, pages 100121.
Crossref
Crossref
John Paul Savaryn, Jun Sun, Junli Ma, Gary J. Jenkins & David M. Stresser. (2022) Broad Application of CYP3A4 Liquid Chromatography-Mass Spectrometry Protein Quantification in Hepatocyte Cytochrome P450 Induction Assays Identifies Nonuniformity in mRNA and Protein Induction Responses. Drug Metabolism and Disposition 50:2, pages 105-113.
Crossref
Crossref
Marilyn Silva & Ryan Kin-Hin Kwok. (2022) Use of computational toxicology tools to predict in vivo endpoints associated with Mode of Action and the endocannabinoid system: A case study with chlorpyrifos, chlorpyrifos-oxon and Δ9Tetrahydrocannabinol. Current Research in Toxicology 3, pages 100064.
Crossref
Crossref
S. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. HopS. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. Hop. 2022. Discovery DMPK Quick Guide. Discovery DMPK Quick Guide
175
215
.
Philip Butler & Robert J. Riley. 2022. The ADME Encyclopedia. The ADME Encyclopedia
448
456
.
Philip Butler & Robert J. Riley. 2022. The ADME Encyclopedia. The ADME Encyclopedia
537
547
.
Veronica Lizano-Fallas, Ana Carrasco del Amor & Susana Cristobal. (2021) Systematic analysis of chemical-protein interactions from zebrafish embryo by proteome-wide thermal shift assay, bridging the gap between molecular interactions and toxicity pathways. Journal of Proteomics 249, pages 104382.
Crossref
Crossref
Hua Lv, Wei Zhu & Hong Shen. 2021. The Medicinal Chemist's Guide to Solving ADMET Challenges. The Medicinal Chemist's Guide to Solving ADMET Challenges
198
219
.
Wei Qu, David M. Crizer, Michael J. DeVito, Suramya Waidyanatha, Menghang Xia, Keith Houck & Stephen S. Ferguson. (2021) Exploration of xenobiotic metabolism within cell lines used for Tox21 chemical screening. Toxicology in Vitro 73, pages 105109.
Crossref
Crossref
Fabio Bachmann, Urs Duthaler, Henriette E. Meyer zu Schwabedissen, Maxim Puchkov, Jörg Huwyler, Manuel Haschke & Stephan Krähenbühl. (2021) Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Clinical Pharmacology & Therapeutics 109:6, pages 1505-1516.
Crossref
Crossref
Adrian Hall, Hugues Chanteux, Karelle MénochetMarie Ledecq & Monika-Sarah E. D. Schulze. (2021) Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches. Journal of Medicinal Chemistry 64:10, pages 6413-6522.
Crossref
Crossref
Marilyn H. Silva. (2021) Chlorpyrifos and Δ9 Tetrahydrocannabinol exposure and effects on parameters associated with the endocannabinoid system and risk factors for obesity. Current Research in Toxicology 2, pages 296-308.
Crossref
Crossref
Philip Butler & Robert J. Riley. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
9
.
Philip Butler & Robert J. Riley. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
11
.
Susan Wong. 2021. Cytochrome P450. Cytochrome P450
193
215
.
Siva Nageswara Rao Gajula, Gangireddy Navitha Reddy, Dannarm Srinivas Reddy & Rajesh Sonti. (2020) Pharmacokinetic drug–drug interactions: an insight into recent US FDA-approved drugs for prostate cancer. Bioanalysis 12:22, pages 1647-1664.
Crossref
Crossref
Delilah F.G. Hendriks, Sabine U. Vorrink, Tomas Smutny, Sarah C. Sim, Åsa Nordling, Shahid Ullah, Masaki Kumondai, Barry C. Jones, Inger Johansson, Tommy B. Andersson, Volker M. Lauschke & Magnus Ingelman‐Sundberg. (2020) Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three‐Dimensional Spheroid Cultures of Primary Human Hepatocytes. Clinical Pharmacology & Therapeutics 108:4, pages 844-855.
Crossref
Crossref
Nina Isoherranen & Robert S. Foti. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
273
309
.
Kristen R Ryan, Madelyn C Huang, Stephen S Ferguson, Suramya Waidyanatha, Sreenivasa Ramaiahgari, Julie R Rice, Paul E Dunlap, Scott S Auerbach, Esra Mutlu, Tim Cristy, Jessica Peirfelice, Michael J DeVito, Stephanie L Smith-Roe & Cynthia V Rider. (2019) Evaluating Sufficient Similarity of Botanical Dietary Supplements: Combining Chemical and In Vitro Biological Data. Toxicological Sciences 172:2, pages 316-329.
Crossref
Crossref
Meghnad G. JoshiArvind GulbakeShivaji B. KashtePrachi BorudeUdayan ApteSuchitra Sumitran-Holgersson. (2019) Xenobiotic-Induced Fetal Hepatocyte Maturation. Applied In Vitro Toxicology 5:4, pages 180-186.
Crossref
Crossref
Christian Schulz, Sarah Kammerer & Jan-Heiner Küpper. (2019) NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies. Clinical Hemorheology and Microcirculation 73:1, pages 249-260.
Crossref
Crossref
Luca Docci, Neil Parrott, Stephan Krähenbühl & Stephen Fowler. (2019) Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico Tools. SLAS Discovery 24:5, pages 523-536.
Crossref
Crossref
Keiichi KimuraIkki HoriguchiTaketomo KidoAtsushi MiyajimaYasuyuki Sakai. (2019) Enhanced Hepatic Differentiation of Human Induced Pluripotent Stem Cells Using Gas-Permeable Membrane. Tissue Engineering Part A 25:5-6, pages 457-467.
Crossref
Crossref
Kouichi Yoshinari & Mika Nagai. (2019) In silico prediction models of the induction of drug-metabolizing enzymes for drug discovery創薬に活用可能なin silico手法による酵素誘導評価法. Folia Pharmacologica Japonica 153:4, pages 186-191.
Crossref
Crossref
Jenni Küblbeck & Paavo Honkakoski. 2019. Nuclear Receptors. Nuclear Receptors
163
173
.
Ryosuke Negoro, Kazuo Takayama, Kanae Kawai, Kazuo Harada, Fuminori Sakurai, Kazumasa Hirata & Hiroyuki Mizuguchi. (2018) Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies. Stem Cell Reports 11:6, pages 1539-1550.
Crossref
Crossref
Mika Nagai, Takuomi Hosaka, Masahiro Satsukawa & Kouichi Yoshinari. (2018) Characterization of CYP2C Induction in Cryopreserved Human Hepatocytes and Its Application in the Prediction of the Clinical Consequences of the Induction. Journal of Pharmaceutical Sciences 107:9, pages 2479-2488.
Crossref
Crossref
Natasha R. Catlin, Bradley J. Collins, Scott S. Auerbach, Stephen S. Ferguson, James M. Harnly, Chris Gennings, Suramya Waidyanatha, Glenn E. Rice, Stephanie L. Smith-Roe, Kristine L. Witt & Cynthia V. Rider. (2018) How similar is similar enough? A sufficient similarity case study with Ginkgo biloba extract. Food and Chemical Toxicology 118, pages 328-339.
Crossref
Crossref
Asmaa S. Salman, Dalia M. Aboelhassa, Eman R. Zaki, Nevein S.M. Saleh & Karima F. Mahrous. (2018) Protective Effects of Echinacea purpurea against the Genotoxic and Biochemical Damage Induced by Benzo[a]pyrene in Mice. Journal of Biological Sciences 18:4, pages 165-177.
Crossref
Crossref
Niresh Hariparsad, Diane Ramsden, Jairam Palamanda, Joshua G. Dekeyser, Odette A. Fahmi, Jane R. Kenny, Heidi Einolf, Michael Mohutsky, Magalie Pardon, Y. Amy Siu, Liangfu Chen, Michael Sinz, Barry Jones, Robert Walsky, Shannon Dallas, Suresh K. Balani, George Zhang, David Buckley & Donald Tweedie. (2017) Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control. Drug Metabolism and Disposition 45:10, pages 1049-1059.
Crossref
Crossref
Ryuji Kato & Jack Uetrecht. (2017) Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes. Chemical Research in Toxicology 30:6, pages 1327-1332.
Crossref
Crossref
Jennifer Q. Dong, James R. Gosset, Odette A. Fahmi, Zhiwu Lin, Jeffrey R. Chabot, Steven G. Terra, Vu Le, Kristin Chidsey, Parya Nouri, Albert Kim, Leonard Buckbinder & Amit S. Kalgutkar. (2017) Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome. Drug Metabolism and Disposition 45:5, pages 501-511.
Crossref
Crossref
Rongjun Zuo, Feng Li, Sweta Parikh, Li Cao, Kirsten L. Cooper, Yulong Hong, Jin Liu, Ronald A. Faris, Daochuan Li & Hongbing Wang. (2017) Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach. Drug Metabolism and Disposition 45:2, pages 198-207.
Crossref
Crossref
David M. Salerno, Demetra Tsapepas, Apostolos Papachristos, Jae-Hyung Chang, Spencer Martin, Mark A. Hardy & Jaclyn McKeen. (2017) Direct oral anticoagulant considerations in solid organ transplantation: A review. Clinical Transplantation 31:1, pages e12873.
Crossref
Crossref
Jinhua Qin, Mingyang Chang, Shuyong Wang, Zhenbo Liu, Wei Zhu, Yi Wang, Fang Yan, Jian Li, Bowen Zhang, Guifang Dou, Jiang Liu, Xuetao Pei & Yunfang Wang. (2016) Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells. Scientific Reports 6:1.
Crossref
Crossref
Ryosuke Negoro, Kazuo Takayama, Yasuhito Nagamoto, Fuminori Sakurai, Masashi Tachibana & Hiroyuki Mizuguchi. (2016) Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells. Biochemical and Biophysical Research Communications 472:4, pages 631-636.
Crossref
Crossref
B. Lucendo-Villarin, H. Rashidi, K. Cameron & D. C. Hay. (2016) Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. Journal of Materials Chemistry B 4:20, pages 3433-3442.
Crossref
Crossref
Arnout Schepers, Cheri Li, Arnav Chhabra, Benjamin Tschudy Seney & Sangeeta Bhatia. (2016) Engineering a perfusable 3D human liver platform from iPS cells. Lab on a Chip 16:14, pages 2644-2653.
Crossref
Crossref
Mark S. Luer & Scott R. Penzak. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
3
27
.
Brian G. Lake & Roger J. Price. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
309
332
.
Elena Foster, Jungmok You, Christian Siltanen, Dipali Patel, Amranul Haque, Leif Anderson & Alexander Revzin. (2015) Heparin hydrogel sandwich cultures of primary hepatocytes. European Polymer Journal 72, pages 726-735.
Crossref
Crossref
Souzan B. Yanni. 2015. Translational ADMET for Drug Therapy. Translational ADMET for Drug Therapy
139
178
.
Jenni Küblbeck, Teemu Anttila, Juha T. Pulkkinen & Paavo Honkakoski. (2015) Improved assays for xenosensor activation based on reverse transfection. Toxicology in Vitro 29:7, pages 1759-1765.
Crossref
Crossref
Sarada D. Ramachandran, Aurélie Vivarès, Sylvie Klieber, Nicola J. Hewitt, Bernhard Muenst, Stefan Heinz, Heike Walles & Joris Braspenning. (2015)
Applicability of second-generation upcyte
®
human hepatocytes for use in CYP inhibition and induction studies
. Pharmacology Research & Perspectives 3:5, pages e00161.
Crossref
Crossref
Yuki Kutsuno, Rika Hirashima, Masaya Sakamoto, Hiroko Ushikubo, Hirofumi Michimae, Tomoo Itoh, Robert H. Tukey & Ryoichi Fujiwara. (2015)
Expression of
UDP-Glucuronosyltransferase 1
(
UGT1
) and Glucuronidation Activity toward Endogenous Substances in Humanized
UGT1
Mouse Brain
. Drug Metabolism and Disposition 43:7, pages 1071-1076.
Crossref
Crossref
Jimena LavanderaSilvina RuspiniAlcira BatlleAna María Buzaleh. (2015) Cytochrome P450 expression in mouse brain: specific isoenzymes involved in Phase I metabolizing system of porphyrinogenic agents in both microsomes and mitochondria. Biochemistry and Cell Biology 93:1, pages 102-107.
Crossref
Crossref
Hyeon-Uk Jeong, Ji Young Lee, Soon-Sang Kwon, Ju Hyun Kim, Young-Mok Kim, Sung-Woon Hong, Sung Hum Yeon, Sun-Mee Lee, Yong-Yeon Cho & Hye Suk Lee. (2014) Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes. Archives of Pharmacal Research 38:2, pages 171-177.
Crossref
Crossref
Payman Shahabi, Gérard Siest, Urs A. Meyer & Sophie Visvikis-Siest. (2014) Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders. Pharmacology & Therapeutics 144:2, pages 134-161.
Crossref
Crossref
Sara De Martin, Daniela Gabbia, Giovanna Albertin, Maria Martina Sfriso, Claudia Mescoli, Laura Albertoni, Giovanna Paliuri, Sergio Bova & Pietro Palatini. (2014) Differential Effect of Liver Cirrhosis on the Pregnane X Receptor–Mediated Induction of CYP3A1 and 3A2 in the Rat. Drug Metabolism and Disposition 42:10, pages 1617-1626.
Crossref
Crossref
Stephen S. Ferguson & Jessica A. Bonzo. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
441
484
.
Christopher D. Houle, Gregory L. Finch, Robert J. Mauthe, David M. Potter, Jacqueline A. Walisser, Iain B. Gardner & Robert H. DeWit. (2013) Effects of Lersivirine on Canine and Rodent Thyroid Function. Toxicologic Pathology 42:5, pages 897-912.
Crossref
Crossref
Jarrod Bailey, Michelle Thew & Michael Balls. (2014) An Analysis of the Use of Animal Models in Predicting Human Toxicology and Drug Safety. Alternatives to Laboratory Animals 42:3, pages 181-199.
Crossref
Crossref
Guillaume Baneyx, Neil Parrott, Christophe Meille, Athanassios Iliadis & Thierry Lavé. (2014) Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: Influence of time between substrate and inducer administration. European Journal of Pharmaceutical Sciences 56, pages 1-15.
Crossref
Crossref
Feng Chen, Xiao-Hui Rao, Jin-Lian Yang, Ming-Xing Pan, Yi Gao, Zhen-Lin Li, Yang Li, You-Fu Zhu & Yan Wang. (2014) Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD. PLoS ONE 9:5, pages e95752.
Crossref
Crossref
Scott J. Brantley, Aneesh A. Argikar, Yvonne S. Lin, Swati Nagar & Mary F. Paine. (2014) Herb–Drug Interactions: Challenges and Opportunities for Improved Predictions. Drug Metabolism and Disposition 42:3, pages 301-317.
Crossref
Crossref
Christian Wiegand, Nicola J. Hewitt, Hans F. Merk & Kerstin Reisinger. (2014) Dermal Xenobiotic Metabolism: A Comparison between Native Human Skin, Four in vitro Skin Test Systems and a Liver System. Skin Pharmacology and Physiology 27:5, pages 263-275.
Crossref
Crossref
Monica Singer, Carlo Sensenhauser & Shannon Dallas. 2014. Optimization in Drug Discovery. Optimization in Drug Discovery
237
253
.
Mohammad Asif. (2013) Role of certain nutritional supplements and biological regulators in the epilepsy. TANG [HUMANITAS MEDICINE] 3:4, pages 29.1-29.11.
Crossref
Crossref
Ali Navid, David M Ng, Benjamin J Stewart, Sergio E Wong & Felice C Lightstone. (2013) Quantitative In Silico analysis of transient metabolism of acetaminophen and associated causes of hepatotoxicity in humans. In Silico Pharmacology 1:1.
Crossref
Crossref
Tonika Bohnert & Lawrence L. Gan. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
61
.
Joshua C. Kwekel, Varsha G. Desai, Carrie L. Moland, Vikrant Vijay & James C. Fuscoe. (2013) Life Cycle Analysis of Kidney Gene Expression in Male F344 Rats. PLoS ONE 8:10, pages e75305.
Crossref
Crossref
Míriam Cristina Sakuragui Matuo, Rafael Teruiti de Oliveira Takamoto, Irene Satiko Kikuchi & Terezinha de Jesus Andreoli Pinto. (2013) Effect of bixin and norbixin on the expression of cytochrome P450 in HepG2 cell line. Cell Biology International 37:8, pages 843-848.
Crossref
Crossref
Shannon Dallas, Carlo Sensenhauser, Souvik Chattopadhyay & Jose Silva. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
24
.
Xiaocui Ma, Yuyou Duan, Benjamin Tschudy-Seney, Garrett Roll, Iman Saramipoor Behbahan, Tijess P. Ahuja, Vladimir Tolstikov, Charles Wang, Jeannine McGee, Shiva Khoobyari, Jan A. Nolta, Holger Willenbring & Mark A. Zern. (2013) Highly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem Cells. Stem Cells Translational Medicine 2:6, pages 409-419.
Crossref
Crossref
Christoffer Bundgaard, Lassina Badolo & John P. Redrobe. (2013) RO4938581, a GABAAα5 modulator, displays strong CYP1A2 autoinduction properties in rats. Biochemical Pharmacology 85:9, pages 1363-1369.
Crossref
Crossref
Silvio Caccia, Luca Pasina & Alessandro Nobili. (2013) How pre-marketing data can be used for predicting the weight of drug interactions in clinical practice. European Journal of Internal Medicine 24:3, pages 217-221.
Crossref
Crossref
Ariel R. Topletz, Huong N. Le, Nora Lee, John D. Chapman, Edward J. Kelly, Joanne Wang & Nina Isoherranen. (2013) Hepatic Cyp2d and Cyp26a1 mRNAs and Activities Are Increased During Mouse Pregnancy. Drug Metabolism and Disposition 41:2, pages 312-319.
Crossref
Crossref
Peter Bünning. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
975
987
.
Alexander V. LyubimovPeter L. Bullock & Olga V. Trubetskoy. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
26
.
Alexander V. LyubimovKarthik Venkatakrishnan. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
62
.
Alexander V. LyubimovCostas Ioannides & Brian G. Lake. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
26
.
Christine Götz, Roland Pfeiffer, Julia Tigges, Veronika Blatz, Christine Jäckh, Eva‐Maria Freytag, Eric Fabian, Robert Landsiedel, Hans F Merk, Jean Krutmann, Robert J Edwards, Camilla Pease, Carsten Goebel, Nicola Hewitt & Ellen Fritsche. (2012)
Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte‐based cell culture as
in vitro
alternatives for chemical testing: activating enzymes (Phase I)
. Experimental Dermatology 21:5, pages 358-363.
Crossref
Crossref
Jianling Wang & Leslie Bell. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
129
159
.
Adrian J. Fretland, Anshul Gupta, Peijuan Zhu & Catherine L. Booth‐Genthe. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
233
251
.
Guillaume Baneyx, Yumi Fukushima & Neil Parrott. (2012) Use of physiologically based pharmacokinetic modeling for assessment of drug–drug interactions. Future Medicinal Chemistry 4:5, pages 681-693.
Crossref
Crossref
Johannes Kirchmair, Mark J. Williamson, Jonathan D. Tyzack, Lu Tan, Peter J. Bond, Andreas Bender & Robert C. Glen. (2012) Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms. Journal of Chemical Information and Modeling 52:3, pages 617-648.
Crossref
Crossref
Shaojun Shi & Ulrich Klotz. (2012) Drug Interactions with Herbal Medicines. Clinical Pharmacokinetics 51:2, pages 77-104.
Crossref
Crossref
Junling Yang, Minxia M. He, Wei Niu, Steven A. Wrighton, Li Li, Yang Liu & Chuan Li. (2012) Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. British Journal of Clinical Pharmacology 73:2, pages 268-284.
Crossref
Crossref
Alexander V. LyubimovMark Fielden & Christine Karbowski. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
29
.
Alexander V. LyubimovTonika Bohnert & Chandra Prakash. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
42
.
Olaf Schaefer, Sumio Ohtsuki, Hirotaka Kawakami, Tae Inoue, Stephanie Liehner, Asami Saito, Atsushi Sakamoto, Naoki Ishiguro, Takehisa Matsumaru, Tetsuya Terasaki & Thomas Ebner. (2012) Absolute Quantification and Differential Expression of Drug Transporters, Cytochrome P450 Enzymes, and UDP-Glucuronosyltransferases in Cultured Primary Human Hepatocytes. Drug Metabolism and Disposition 40:1, pages 93-103.
Crossref
Crossref
Yi Yang, Rita Ciurlionis, Kenneth Kowalkowski, Kennan C. Marsh, William M. Bracken & Eric A.G. Blomme. (2012) N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in rats. Toxicology Letters 208:1, pages 82-91.
Crossref
Crossref
Wayne Y.W. Lee, Xuelin Zhou, Penelope M.Y. Or, Yiu Wa Kwan & John H.K. Yeung. (2012) Tanshinone I increases CYP1A2 protein expression and enzyme activity in primary rat hepatocytes. Phytomedicine 19:2, pages 169-176.
Crossref
Crossref
Donna M. Platt & James K. Rowlett. 2012. Nonhuman Primates in Biomedical Research. Nonhuman Primates in Biomedical Research
817
839
.
Irene Antolino-Lobo, Jan Meulenbelt, Jeffrey Molendijk, Sandra M. Nijmeijer, Peter Scherpenisse, Martin van den Berg & Majorie B.M. van Duursen. (2011) Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants. Toxicology 289:2-3, pages 175-184.
Crossref
Crossref
Dong Hee Na, Hye Young Ji, Eun Ji Park, Myung Sun Kim, Kwang-Hyeon Liu & Hye Suk Lee. (2011) Evaluation of metabolism-mediated herb-drug interactions. Archives of Pharmacal Research 34:11, pages 1829-1842.
Crossref
Crossref
Grace Zhixia Yan, Kim L. R. Brouwer, Gary M. Pollack, Michael Zhuo Wang, Richard R. Tidwell, James E. Hall & Mary F. Paine. (2011) Mechanisms Underlying Differences in Systemic Exposure of Structurally Similar Active Metabolites: Comparison of Two Preclinical Hepatic Models. Journal of Pharmacology and Experimental Therapeutics 337:2, pages 503-512.
Crossref
Crossref
Irene Antolino-Lobo, Jan Meulenbelt, Sandra M. Nijmeijer, Roel F. Maas-Bakker, Irma Meijerman, Martin van den Berg & Majorie B.M. van Duursen. (2011) 3,4-Methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition. Toxicology Letters 203:1, pages 82-91.
Crossref
Crossref
Lei Guo, Stacey Dial, Leming Shi, William Branham, Jie Liu, Jia-Long Fang, Bridgett Green, Helen Deng, Jim Kaput & Baitang Ning. (2011) Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes. Drug Metabolism and Disposition 39:3, pages 528-538.
Crossref
Crossref
Paola Motta, Nicoletta Pons, Sabrina Pagliarusco, Mario Pellegatti & Fiorenza Bonomo. (2011) Casopitant: In Vitro Data and SimCyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4. Drug Metabolism and Disposition 39:3, pages 363-372.
Crossref
Crossref
Maryam Modarai, Elisabete Silva, Andy Suter, Michael Heinrich & Andreas Kortenkamp. (2011) Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides Do Not Induce CYP3A4 mRNA Expression. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-7.
Crossref
Crossref
Stephanie M. Martinez, Blair U. Bradford, Valerie Y. Soldatow, Oksana Kosyk, Amelia Sandot, Rafal Witek, Robert Kaiser, Todd Stewart, Kirsten Amaral, Kimberly Freeman, Chris Black, Edward L. LeCluyse, Stephen S. Ferguson & Ivan Rusyn. (2010) Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity. Toxicology and Applied Pharmacology 249:3, pages 208-216.
Crossref
Crossref
Karthik Venkatakrishnan, Michael D. Pickard & Lisa L. von Moltke. (2010) A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug Development. Clinical Pharmacokinetics 49:11, pages 703-727.
Crossref
Crossref
Stefano Zamuner, Brendan M. Johnson, Sabrina Pagliarusco, Paolo Fina, Michela Peroni, Monica Fiore, Laurel M. Adams & Sofia A. Fernandes. (2010) Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipine. British Journal of Clinical Pharmacology 70:4, pages 537-546.
Crossref
Crossref
Michael A. Mohutsky, Annette Romeike, Vince Meador, William M. Lee, John Fowler & Sabine Francke-Carroll. (2010) Hepatic Drug-Metabolizing Enzyme Induction and Implications for Preclinical and Clinical Risk Assessment. Toxicologic Pathology 38:5, pages 799-809.
Crossref
Crossref
Daniela Ennulat, Dana Walker, Frances Clemo, Michal Magid-Slav, David Ledieu, Mark Graham, Suzanne Botts & Laura Boone. (2010) Effects of Hepatic Drug-metabolizing Enzyme Induction on Clinical Pathology Parameters in Animals and Man. Toxicologic Pathology 38:5, pages 810-828.
Crossref
Crossref
Peter L. Bullock. 2010. Early Drug Development. Early Drug Development
89
130
.
Amin A. Nomeir. 2010. Early Drug Development. Early Drug Development
25
88
.
Jenni Küblbeck, Mika Reinisalo, Riitta Mustonen & Paavo Honkakoski. (2010) Up-regulation of CYP expression in hepatoma cells stably transfected by chimeric nuclear receptors. European Journal of Pharmaceutical Sciences 40:4, pages 263-272.
Crossref
Crossref
Gernot Zollner, Martin Wagner & Michael Trauner. (2010) Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacology & Therapeutics 126:3, pages 228-243.
Crossref
Crossref
Yuyou Duan, Xiaochui Ma, Wei Zou, Charles Wang, Iman Saramipoor Bahbahan, Tijess P. Ahuja, Vladimir Tolstikov & Mark A. Zern. (2010) Differentiation and Characterization of Metabolically Functioning Hepatocytes from Human Embryonic Stem Cells. Stem Cells 28:4, pages 674-686.
Crossref
Crossref
Izet M. Kapetanovic, Thomas L. Horn, William D. Johnson, Michael J. Cwik, Carol J. Detrisac & David L. McCormick. (2010)
Murine Oncogenicity and Pharmacokinetics Studies of 9-
cis
-UAB30, an RXR Agonist, for Breast Cancer Chemoprevention
. International Journal of Toxicology 29:2, pages 157-164.
Crossref
Crossref
Catherine Abadie-Viollon, Hélène Martin, Nadège Blanchard, Dumrongsak Pekthong, Philippe Bachellier, Georges Mantion, Bruno Heyd, Frantz Schuler, Philippe Coassolo, Eliane Alexandre & Lysiane Richert. (2010) Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions. Toxicology in Vitro 24:1, pages 346-356.
Crossref
Crossref
Akihiro Hisaka, Yoshiyuki Ohno, Takehito Yamamoto & Hiroshi Suzuki. (2010) Prediction of pharmacokinetic drug–drug interaction caused by changes in cytochrome P450 activity using in vivo information. Pharmacology & Therapeutics 125:2, pages 230-248.
Crossref
Crossref
R.I. Sanchez & F.C. Kauffman. 2010. Comprehensive Toxicology. Comprehensive Toxicology
109
128
.
Tonika Bohnert & Liang‐Shang Gan. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
91
176
.
Nelly Aranibar, Vasanthi Bhaskaran, Karl-Heinz Ott, Jeff Vassallo, David Nelson, Lloyd Lecureux, Lei Gong, Steve Stryker & Lois Lehman-McKeeman. (2009) Modulation of ascorbic acid metabolism by cytochrome P450 induction revealed by metabonomics and transcriptional profiling. Magnetic Resonance in Chemistry 47:S1, pages S12-S19.
Crossref
Crossref
Silvio Caccia, Silvio Garattini, Luca Pasina & Alessandro Nobili. (2009) Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies. Drug Safety 32:11, pages 1017-1039.
Crossref
Crossref
Michiko Sugawara, Kiyoshi Okamoto, Tadashi Kadowaki, Kazutomi Kusano, Akiyoshi Fukamizu & Tsutomu Yoshimura. (2009) Inoculation of Human Tumor Cells Alters the Basal Expression but Not the Inducibility of Cytochrome P450 Enzymes in Tumor-Bearing Mouse Liver. Drug Metabolism and Disposition 37:11, pages 2244-2254.
Crossref
Crossref
Stacy S. ShordKanan Shah & Alvina Lukose. (2009) Drug—Botanical Interactions: A Review of the Laboratory, Animal, and Human Data for 8 Common Botanicals. Integrative Cancer Therapies 8:3, pages 208-227.
Crossref
Crossref
Valeria Chu, Heidi J. Einolf, Raymond Evers, Gondi Kumar, David Moore, Sharon Ripp, Jose Silva, Vikram Sinha, Michael Sinz & Andrej Skerjanec. (2009) In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective. Drug Metabolism and Disposition 37:7, pages 1339-1354.
Crossref
Crossref
Dermot F. McGinnity, George Zhang, Jane R. Kenny, Geraldine A. Hamilton, Sara Otmani, Karen R. Stams, Suzzette Haney, Patrick Brassil, David M. Stresser & Robert J. Riley. (2009) Evaluation of Multiple in Vitro Systems for Assessment of CYP3A4 Induction in Drug Discovery: Human Hepatocytes, Pregnane X Receptor Reporter Gene, and Fa2N-4 and HepaRG Cells. Drug Metabolism and Disposition 37:6, pages 1259-1268.
Crossref
Crossref
Stefano Petti. (2009) Lifestyle risk factors for oral cancer. Oral Oncology 45:4-5, pages 340-350.
Crossref
Crossref
L. Richert, G. Tuschl, C. Abadie, N. Blanchard, D. Pekthong, G. Mantion, J.-C. Weber & S.O. Mueller. (2009) Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicology and Applied Pharmacology 235:1, pages 86-96.
Crossref
Crossref
Katsutoshi Yoshizato & Chise Tateno. (2009) A Human Hepatocyte-Bearing Mouse: An Animal Model to Predict Drug Metabolism and Effectiveness in Humans. PPAR Research 2009, pages 1-11.
Crossref
Crossref
Jordan A. Firestone & Sidney M. GospeJr.Jr.. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
401
414
.
Jinghai J. Xu & Li J. Yu. 2008. Drug Efficacy, Safety, and Biologics Discovery. Drug Efficacy, Safety, and Biologics Discovery
1
28
.
Mark J. Graham & Brian G. Lake. (2008) Induction of drug metabolism: Species differences and toxicological relevance. Toxicology 254:3, pages 184-191.
Crossref
Crossref
Ali A. Asadi-Pooya, Scott Mintzer & Michael R. Sperling. (2008) Nutritional supplements, foods, and epilepsy: Is there a relationship?. Epilepsia 49:11, pages 1819-1827.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen, Jukka Hakkola, Paavo Honkakoski, Janne Hukkanen & Hannu Raunio. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Archives of Toxicology 82:10, pages 667-715.
Crossref
Crossref
Paul Baldrick. (2008) Safety evaluation to support First-In-Man investigations I: Kinetic and safety pharmacology studies. Regulatory Toxicology and Pharmacology 51:2, pages 230-236.
Crossref
Crossref